Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taebo Sim

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Frontiers in Pharmacology|June 6, 2019
A Bcr-Abl Inhibitor GNF-2 Attenuates Inflammatory Activation of Glia and Chronic PainGyun Jee Song, Md Habibur Rahman, Mithilesh Kumar Jha, et al.
Cell Death & Disease|May 18, 2022
AK2 is an AMP-sensing negative regulator of BRAF in tumorigenesisHyunjoo Kim, Muhah Jeong, Do-Hyeong Na, et al.
Blood|April 3, 2015
Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approachAtsushi Nonami, Martin Sattler, Ellen Weisberg, et al.
Journal of Medicinal Chemistry|July 8, 2010
A type-II kinase inhibitor capable of inhibiting the T315I "gatekeeper" mutant of Bcr-AblHwan Geun Choi, Pingda Ren, Francisco Adrian, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2008
Discovery of pyrimidine benzimidazoles as Lck inhibitors: part IGuobao Zhang, Pingda Ren, Nathanael S Gray, et al.
Nature Chemical Biology|April 13, 2010
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle functionNicholas Kwiatkowski, Nannette Jelluma, Panagis Filippakopoulos, et al.
European Journal of Medicinal Chemistry|November 19, 2013
Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-onesXianming Deng, Jonathan M Elkins, Jinwei Zhang, et al.
Current Research in Chemical Biology|August 21, 2025
Synthesis and structure-activity relationships of targeted protein degraders for the understudied kinase NEK9SeongShick Ryu, Gillian E Gadbois, Andrew J Tao, et al.
Cell Death Discovery|October 13, 2025
Apomorphine is a novel necroptosis inhibitor targeting mixed lineage kinase domain-like protein oligomerizationMyeonggil Han, Dong-Hyun Seo, Man Sup Kwak, et al.
Cancer Discovery|October 4, 2016
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung CancerMagda Bahcall, Taebo Sim, Cloud P Paweletz, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|June 6, 2019
A Bcr-Abl Inhibitor GNF-2 Attenuates Inflammatory Activation of Glia and Chronic PainGyun Jee Song, Md Habibur Rahman, Mithilesh Kumar Jha, et al.
Cell Death & Disease|May 18, 2022
AK2 is an AMP-sensing negative regulator of BRAF in tumorigenesisHyunjoo Kim, Muhah Jeong, Do-Hyeong Na, et al.
Blood|April 3, 2015
Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approachAtsushi Nonami, Martin Sattler, Ellen Weisberg, et al.
Journal of Medicinal Chemistry|July 8, 2010
A type-II kinase inhibitor capable of inhibiting the T315I "gatekeeper" mutant of Bcr-AblHwan Geun Choi, Pingda Ren, Francisco Adrian, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2008
Discovery of pyrimidine benzimidazoles as Lck inhibitors: part IGuobao Zhang, Pingda Ren, Nathanael S Gray, et al.
Nature Chemical Biology|April 13, 2010
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle functionNicholas Kwiatkowski, Nannette Jelluma, Panagis Filippakopoulos, et al.
European Journal of Medicinal Chemistry|November 19, 2013
Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-onesXianming Deng, Jonathan M Elkins, Jinwei Zhang, et al.
Current Research in Chemical Biology|August 21, 2025
Synthesis and structure-activity relationships of targeted protein degraders for the understudied kinase NEK9SeongShick Ryu, Gillian E Gadbois, Andrew J Tao, et al.
Cell Death Discovery|October 13, 2025
Apomorphine is a novel necroptosis inhibitor targeting mixed lineage kinase domain-like protein oligomerizationMyeonggil Han, Dong-Hyun Seo, Man Sup Kwak, et al.
Cancer Discovery|October 4, 2016
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung CancerMagda Bahcall, Taebo Sim, Cloud P Paweletz, et al.
Pageof 13